HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuharu Sato Selected Research

Submandibular Gland Diseases

8/2014T helper 2 and regulatory T-cell cytokine production by mast cells: a key factor in the pathogenesis of IgG4-related disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuharu Sato Research Topics

Disease

35Immunoglobulin G4-Related Disease
01/2022 - 12/2009
18Lymphoma (Lymphomas)
07/2022 - 06/2009
16Neoplasms (Cancer)
10/2021 - 01/2011
15Lymphadenopathy
01/2019 - 04/2009
14Fibrosis (Cirrhosis)
06/2022 - 01/2013
13Multi-centric Castleman's Disease
06/2022 - 04/2009
12Castleman Disease (Castleman's Disease)
06/2022 - 12/2012
8Lymphoproliferative Disorders (Lymphoproliferative Disorder)
09/2022 - 12/2012
8Inflammation (Inflammations)
06/2022 - 08/2008
8Thrombocytopenia (Thrombopenia)
06/2022 - 01/2013
8Edema (Dropsy)
06/2022 - 01/2013
8Fever (Fevers)
06/2022 - 01/2013
8Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
01/2021 - 07/2009
8B-Cell Lymphoma (Lymphoma, B Cell)
11/2017 - 08/2008
6Hodgkin Disease (Hodgkin's Disease)
01/2022 - 09/2013
6Anemia
03/2020 - 01/2012
5Rheumatoid Arthritis
09/2022 - 01/2012
5Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2022 - 07/2009
5T-Cell Lymphoma (Lymphoma, T Cell)
01/2019 - 01/2013
5Hypoalbuminemia
11/2017 - 01/2012
4Autoimmune Diseases (Autoimmune Disease)
06/2022 - 06/2009
4Spontaneous Remission
01/2022 - 06/2017
4Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
11/2017 - 11/2011
3Renal Insufficiency (Renal Failure)
06/2022 - 10/2021
3Rhinosinusitis
07/2020 - 04/2019
3Hypergammaglobulinemia (Hyperimmunoglobulinemia)
01/2019 - 02/2014
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2015 - 07/2009
2Kimura Disease
01/2022 - 12/2016
2Cytokine Release Syndrome
12/2020 - 10/2019
2Pleural Effusion (Pleural Effusions)
11/2020 - 01/2008
2Abdominal Pain (Pain, Abdominal)
10/2019 - 02/2016
2Infections
10/2019 - 04/2009
2Eosinophilia
04/2019 - 02/2014
2Hyperplasia
01/2018 - 07/2012
2Interstitial Nephritis (Tubulointerstitial Nephritis)
09/2016 - 04/2016
2Sialadenitis
02/2016 - 01/2015
2Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
10/2015 - 07/2014
2Hypersensitivity (Allergy)
01/2015 - 08/2014
2Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2014 - 01/2013
2Adenocarcinoma
10/2013 - 11/2012
2Carcinoma (Carcinomatosis)
10/2013 - 11/2012
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
09/2022
1POEMS Syndrome (Syndrome, POEMS)
06/2022
1Virus Diseases (Viral Diseases)
06/2022
1Paraneoplastic Syndromes (Paraneoplastic Syndrome)
06/2022
1Arthritis (Polyarthritis)
02/2022
1Ulcer
11/2021
1Communicable Diseases (Infectious Diseases)
10/2021
1Head and Neck Neoplasms (Head and Neck Cancer)
03/2021

Drug/Important Bio-Agent (IBA)

36Immunoglobulin G (IgG)IBA
07/2022 - 12/2009
12Immunoglobulins (Immunoglobulin)IBA
07/2022 - 01/2010
12CytokinesIBA
06/2022 - 08/2014
12Interleukin-6 (Interleukin 6)IBA
02/2022 - 04/2009
11C-Reactive ProteinIBA
03/2020 - 04/2009
8Methotrexate (Mexate)FDA LinkGeneric
09/2022 - 01/2013
8Reticulin (Reticular Fiber)IBA
06/2022 - 01/2013
8Immunoglobulin E (IgE)IBA
01/2022 - 04/2009
7ParaffinIBA
04/2020 - 05/2014
7InterleukinsIBA
03/2020 - 01/2012
6Proteins (Proteins, Gene)FDA Link
06/2022 - 03/2011
6Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
09/2021 - 08/2008
5Interleukin-2 Receptors (IL 2 Receptor)IBA
11/2021 - 07/2009
4RNA (Ribonucleic Acid)IBA
01/2022 - 07/2014
4Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2018
4Cytidine DeaminaseIBA
04/2021 - 07/2009
4Immunoglobulin A (IgA)IBA
12/2020 - 01/2012
4Rituximab (Mabthera)FDA Link
12/2020 - 01/2008
4GlucocorticoidsIBA
12/2019 - 09/2017
4T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2018 - 04/2009
4Cyclin D1IBA
11/2017 - 11/2011
4Immunoglobulin M (IgM)IBA
06/2017 - 01/2012
3CollagenIBA
02/2022 - 04/2015
3Interleukin-13IBA
01/2022 - 01/2015
3Interleukin-10 (Interleukin 10)IBA
01/2022 - 08/2014
3DNA (Deoxyribonucleic Acid)IBA
12/2020 - 02/2016
3AntigensIBA
03/2020 - 07/2009
3Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
03/2019 - 01/2012
3SteroidsIBA
03/2019 - 01/2013
3Formaldehyde (Formol)FDA Link
01/2019 - 05/2014
3Anti-Bacterial Agents (Antibiotics)IBA
12/2016 - 10/2015
2AutoantibodiesIBA
06/2022 - 10/2019
2LigandsIBA
03/2021 - 01/2019
2Indicators and Reagents (Reagents)IBA
04/2020 - 10/2015
2IgE Receptors (Fc epsilon RI)IBA
03/2020 - 01/2018
2Alkaline PhosphataseIBA
10/2019 - 02/2016
2Prednisolone (Predate)FDA LinkGeneric
01/2019 - 09/2017
2AntibodiesIBA
01/2018 - 03/2017
2Adrenal Cortex Hormones (Corticosteroids)IBA
04/2016 - 01/2013
2HMGB1 Protein (HMG1)IBA
01/2016 - 12/2007
2Monoclonal AntibodiesIBA
01/2016 - 12/2007
2Interleukin-4 (Interleukin 4)IBA
12/2015 - 01/2015
2Transforming Growth Factors (Transforming Growth Factor)IBA
08/2015 - 01/2015
2CyclinsIBA
05/2013 - 11/2011
2Cyclin D2IBA
05/2013 - 11/2011
1Antiphospholipid AntibodiesIBA
06/2022
1Therapeutic UsesIBA
02/2022
1Brentuximab VedotinIBA
02/2022
1Immune Checkpoint ProteinsIBA
03/2021

Therapy/Procedure

9Therapeutics
02/2022 - 01/2013
4Drug Therapy (Chemotherapy)
01/2021 - 01/2008